The effect of insulin intensification in children and young persons with Type 1 diabetes differs in relation to

R P Dias1, F Brown, C Wyatt

  • 1Department of Paediatric Endocrinology and Diabetes, Royal London Hospital, London, UK.

Insights

Insulin intensification impacts glycaemic control and lipid levels differently across ethnic groups in children with Type 1 diabetes. Black children had poorer glycaemic control, while South Asian children showed higher triglycerides.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Clinical Research

Background:

  • Type 1 diabetes management in pediatric populations requires tailored approaches.
  • Ethnic variations in metabolic health and disease progression are increasingly recognized.
  • Understanding these differences is crucial for optimizing treatment strategies.

Purpose of the Study:

  • To investigate the influence of ethnicity on glycaemic control and lipid profiles in children and young persons with Type 1 diabetes.
  • To evaluate the effectiveness of insulin intensification across diverse ethnic groups.
  • To identify ethnic-specific challenges in managing Type 1 diabetes.

Main Methods:

  • Prospective observational study over 3 years.
  • Inclusion of 231 children and young persons (40% white, 28% South Asian, 32% black).
  • Intensive insulin therapy offered, with data analyzed at year 3 comparing ethnic groups.

Main Results:

  • Significant ethnic differences in HbA1c levels observed (P=0.007).
  • South Asian children had lower HDL cholesterol and higher triglycerides (P=0.001).
  • Black ethnicity linked to poorer glycaemic control (P<0.001); South Asian ethnicity linked to higher triglycerides (P<0.001), independent of HbA1c.

Conclusions:

  • Insulin intensification's effect on glycaemic control and lipid profiles varies by ethnicity in pediatric Type 1 diabetes.
  • Targeted interventions may be necessary to address ethnic disparities in diabetes management.
  • Further research into the underlying mechanisms of these ethnic differences is warranted.
Abstract

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...